Navigation For Mobile

Monthly Archives: July 2019

How Pharma Controls Generic & NCE Manufacturing Costs by Backward Integrating APIs Ingredients

The pharma industry is facing some outsized business challenges at present – from burgeoning trade wars to downward-pricing pressures and increased regulatory scrutiny. More than one conversation our team members…

Posted in APIs, generic, Neuland Labs, supply chain | Tagged , , | Comments Off on How Pharma Controls Generic & NCE Manufacturing Costs by Backward Integrating APIs Ingredients

How the Valsartan Contamination Happened: Its Context & Implications

Last year’s valsartan contamination and recall brought some surprising chemical synthesis issues to light in the pharma industry. While the reactions used in generic valsartan production are known to be…

Posted in FDA, generic, method development, process chemistry, QA/QC, Quality, synthesis | Tagged , , , , , | Comments Off on How the Valsartan Contamination Happened: Its Context & Implications